- Home
- WRD vs APGE Comparison
WRD vs APGE Comparison
Compare WRD & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRD
- APGE
- Stock Information
- Founded
- WRD 2017
- APGE 2022
- Country
- WRD China
- APGE United States
- Employees
- WRD N/A
- APGE N/A
- Industry
- WRD
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WRD
- APGE Health Care
- Exchange
- WRD NYSE
- APGE Nasdaq
- Market Cap
- WRD 2.0B
- APGE 2.1B
- IPO Year
- WRD 2024
- APGE 2023
- Fundamental
- Price
- WRD $9.90
- APGE $36.64
- Analyst Decision
- WRD Buy
- APGE Strong Buy
- Analyst Count
- WRD 2
- APGE 4
- Target Price
- WRD $22.00
- APGE $91.33
- AVG Volume (30 Days)
- WRD 28.2M
- APGE 589.2K
- Earning Date
- WRD 05-21-2025
- APGE 05-12-2025
- Dividend Yield
- WRD N/A
- APGE N/A
- EPS Growth
- WRD N/A
- APGE N/A
- EPS
- WRD N/A
- APGE N/A
- Revenue
- WRD $49,940,881.00
- APGE N/A
- Revenue This Year
- WRD N/A
- APGE N/A
- Revenue Next Year
- WRD $224.43
- APGE $743.14
- P/E Ratio
- WRD N/A
- APGE N/A
- Revenue Growth
- WRD N/A
- APGE N/A
- 52 Week Low
- WRD $6.03
- APGE $26.20
- 52 Week High
- WRD $44.00
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- WRD N/A
- APGE 44.68
- Support Level
- WRD N/A
- APGE $39.00
- Resistance Level
- WRD N/A
- APGE $38.04
- Average True Range (ATR)
- WRD 0.00
- APGE 1.91
- MACD
- WRD 0.00
- APGE -0.46
- Stochastic Oscillator
- WRD 0.00
- APGE 14.32
About WRD WERIDE INC. SPON ADS EACH REP 3 CL A ORD SHS
WeRide Inc operates in the autonomous driving industry. The company has developed a universal autonomous driving technology platform that integrates full-stack software algorithms, modularized hardware solutions, and a cloud-based infrastructure platform. The company provides autonomous driving products and services from L2 to L4 vehicles. The products of the company includes Robotaxi, Robobus, Robovan, Robosweeper, and others. The company earns its revenue from the People's Republic of China.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.